In this week's episode Helena and Isabel were honoured to be joined by Rino Rappuoli, Head of External R&D and Chief Scientist at GSK Vaccines. He discusses his career inspiration and journey; his work on novel scientific concepts such as reverse vaccinology, which modern vaccines are based on; and his interest in meningitis, as well as the lasting impact of COVID-19 on the vaccine landscape, how he sees the field developing in future and what investment and innovation is needed from pharma to achieve his vision. 

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content: 

Keeping the spark alive in vaccine development https://www.emg-gold.com/post/keeping-the-spark-alive-in-vaccine-development 

GSK's Judy Stewart on vaccines https://www.emg-gold.com/post/we-ve-lost-the-focus-that-we-had-on-routine-vaccination-of-preventable-diseases  

The return of the vaccines https://www.emg-gold.com/post/the-return-of-the-vaccines 

Is mRNA the future of vaccine technology? https://www.emg-gold.com/_files/ugd/b8a9db_63ca75dce7a64cd39b356ac1ffb18358.pdf 

[Yesterday 15:46] Helena Beer

Top tips for digital innovation and the future of patient centricity

In this week’s episode of The GOLD Podcast, Helena is joined by Konrad Dobschuetz, National Director at NHS Innovation Accelerator and Chief Enterprise Officer at UCL Partners, who discusses all things digital innovation. They chat about his transition from the fashion industry to pharma, some digital innovation top tips for companies and his new role at the NHS and the importance of collaboration, plus his take on how the humble automobile may someday turn into a diagnostic tool. And in ‘news you might have missed’, Helena discusses the latest from Boehringer Ingelheim, Sanofi and GSK.

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:

Meet GOLD's catalyst - digital innovator, Davidek Herron: https://www.emg-gold.com/post/podcast-catalyst-digital-innovator-davidek-herron

Digitalisation: moving past paperless: https://www.emg-gold.com/post/digitalisation-moving-past-paperless

Reframing pharma's bad boy reputation https://www.emg-gold.com/post/reframing-pharma-s-bad-boy-reputation

Taking a bet on blockchain https://www.emg-gold.com/post/taking-a-bet-on-blockchain

This week’s episode features a fascinating conversation with Samin Saeed, UK Chief Scientific Officer and Medical Director at Novartis UK. She discusses a whole host of medical affairs-related issues, including the transition from medicine to pharma, cross-functionality, commercial versus medical affairs, and lots more besides, including a fascinating discussion about leadership, company culture and soft skills development. And ‘news you might have missed’ focuses on the European life sciences gender pay gap and new investment for Novartis.

 

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:

Preparing MSLs for the spotlight https://www.emg-gold.com/post/preparing-msls-for-the-spotlight

Juby Jacob-Nara on medical affairs https://www.emg-gold.com/post/juby-jacob-nara-on-medical-affairs

Aliya Omer on gender equality https://www.emg-gold.com/post/podcast-aliya-omer-on-gender-equality

Reframing pharma’s bad boy reputation https://www.emg-gold.com/post/reframing-pharma-s-bad-boy-reputation

Elevating pharma’s parental leave policies https://www.emg-gold.com/post/elevating-pharma-s-parental-leave-policies

This week, Marc and Helena are joined in the podcast studio by Pav Rishiraj, Director and Head of Pharmacovigilance at Ipsen, to shed some light on this often-overlooked field of pharma. He discusses his career journey in pharmacovigilance and how, in his experience, the field has changed; the importance of pharmacovigilance as a strategic enabler within businesses; and the outlook for the future of the field in terms of AI and automation. Helena also leads a short tribute to Her Majesty Queen Elizabeth II.

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:

The physics of pharmacovigilance https://www.emg-gold.com/post/the-physics-of-pharmacovigilance

RWE, the metrics of medical affairs and TikTok marketing https://www.emg-gold.com/post/podcast-real-world-evidence-the-metrics-of-medical-affairs-and-tiktok-marketing

It's good to be back! To celebrate the launch of Season 3 of The GOLD Podcast, Marc and Helena bring you a special extended version of our conversation with GOLD’s latest catalyst interviewee Dr Juby Jacob-Nara, Vice President and Global Medical Head for Respiratory, Allergy and Gastro-Intestinal Diseases, Sanofi. She speaks to Assistant Editor Isabel O’Brien about her move from medicine to medical affairs, her passion for cross-functional learning and how former physicians can empower themselves to succeed in the pharmaceutical industry.  

 

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:

 

Dr Juby Jacob-Nara on making it medical affairs https://www.emg-gold.com/post/juby-jacob-nara-on-medical-affairs

Preparing MSLs for the spotlight https://www.emg-gold.com/post/preparing-msls-for-the-spotlight

Luca Dezzani and Luisa Luciani-Silverman on medical affairs https://www.emg-gold.com/post/podcast-luca-dezzani-and-luisa-luciani-silverman-on-medical-affairs

Medical affairs evolution and the future for MSLs https://www.emg-gold.com/post/podcast-medical-affairs-evolution-and-the-future-for-msls

RWE, the metrics of medical affairs and TikTok marketing https://www.emg-gold.com/post/podcast-real-world-evidence-the-metrics-of-medical-affairs-and-tiktok-marketing

For our fifth and final GOLD Nugget of season 2, Helena looks back to one of our most popular episodes featuring Davidek Herron, Global Head of Digital at Roche. In these snippets, Davidek gives some great insights into what digital transformation means to him, drawing upon his time playing professional basketball in New York to illustrate his move into the pharma industry and some tips on learning from failure.

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:

Davidek’s full episode: https://www.emg-gold.com/post/podcast-catalyst-digital-innovator-davidek-herron

Davidek Herron on digital transformation: https://www.emg-gold.com/post/davidek-herron-on-digital-transformation

Bridging the digital health divide: https://www.emg-gold.com/post/bridging-the-digital-health-divide

In this GOLD nugget, Helena looks back at thoughts shared by Aliya Omer, Vice President and Head of Global Portfolio and Program Strategy at Kite Pharma from our special International Women’s Day episode. Aliya reflects on her time playing basketball in her youth and fighting for gender equality both on and off the court, some key role models in her life and the importance of listening to engage rather than to reply.

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:

Aliya’s full episode: https://www.emg-gold.com/post/podcast-international-womens-day-special

Bayer in top spot for equality, diversity and inclusion: https://www.emg-gold.com/post/bayer-in-top-spot-for-equality-diversity-and-inclusion

Setting the stage for a more equitable future: https://www.emg-gold.com/post/setting-the-stage-for-a-more-equitable-future

Diversity: from ideas to action: https://www.emg-gold.com/post/diversity-from-ideas-to-action

This GOLD Nugget episode sees Helena reflect on some of the insights offered by Laurence Woollard, haemophilia patient advocate and Founder and Director of On The Pulse Consultancy. In these clips, Laurence shares his personal experience of living with haemophilia and his journey into patient advocacy, the knowledge gap between the pharmaceutical industry and patients living with rare diseases and more.

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:

Laurence’s full episode: https://www.emg-gold.com/post/podcast-digital-solutions-cell-and-gene-therapy-and-haemophilia-in-focus

The progress and pain points of patient centricity: https://www.emg-gold.com/post/the-progress-and-pain-points-of-patient-centricity

The rare disease disparity: https://www.emg-gold.com/post/the-rare-disease-disparity

BioMarin supports haemophilia documentary initiative https://www.emg-gold.com/post/biomarin-supports-haemophilia-documentary-initiative

Roche renews haemophilia pledge https://www.emg-gold.com/post/roche-renews-haemophilia-pledge

For this week’s GOLD nugget, Helena highlights not one but two of GOLD’s previous guests from the world of Medical Affairs: Luca Dezzani, Vice President, Oncology Medical Affairs, Johnson & Johnson, and Luisa Luciani-Silverman, US Medical Head of Immuno-Oncology, AstraZeneca. They explore the potential value that can come from collaborating with different industries and some tips for measuring the value of medical affairs – it’s not one to be missed!

 

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:

Luca’s full episode: https://www.emg-gold.com/post/podcast-medical-affairs-evolution-and-the-future-for-msls

Luisa’s full episode: https://www.emg-gold.com/post/podcast-real-world-evidence-the-metrics-of-medical-affairs-and-tiktok-marketing

The Leap from Medicine to Medical Affairs: https://www.emg-gold.com/post/the-leap-from-medicine-to-medical-affairs

The GOLD Podcast may be on a break, but Helena is still here to provide you with some great insights – or GOLD Nuggets, if you will – from key opinion leaders in the pharmaceutical industry. In this special episode, she looks back at the very first episode of Season 2 which featured Judy Stewart, Senior Vice President and Head of US Vaccines at GSK. Helena considers some of the gold nuggets that Judy shared, including insights on both the vaccine industry and her approach to leadership. If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:   Judy's full podcast episode: https://www.emg-gold.com/post/vaccines-leadership-and-blockchain Judy's Catalyst interview https://www.emg-gold.com/post/we-ve-lost-the-focus-that-we-had-on-routine-vaccination-of-preventable-diseases GSK warns against routine vaccine complacency https://www.emg-gold.com/post/gsk-warns-against-routine-vaccine-complacency Haleon demerger completed by GSK https://www.emg-gold.com/post/haleon-demerger-completed-by-gsk